Hudson Bay Capital Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-150,000
| Closed | -$5.19M | – | 972 |
|
|
2025
Q1 | $5.19M | Buy |
150,000
+37,465
| +33% | +$1.3M | 0.02% | 344 |
|
|
2024
Q4 | $3.09M | Buy |
+112,535
| New | +$3.09M | 0.01% | 431 |
|
|
2024
Q3 | – | Sell |
-38,946
| Closed | -$987K | – | 658 |
|
|
2024
Q2 | $987K | Buy |
+38,946
| New | +$987K | ﹤0.01% | 494 |
|
|
2023
Q2 | – | Sell |
-72,300
| Closed | -$1.2M | – | 781 |
|
|
2023
Q1 | $1.2M | Buy |
+72,300
| New | +$1.2M | 0.01% | 531 |
|
|
2022
Q4 | – | Sell |
-30,000
| Closed | -$298K | – | 940 |
|
|
2022
Q3 | $298K | Sell |
30,000
-70,000
| -70% | -$695K | ﹤0.01% | 867 |
|
|
2022
Q2 | $908K | Buy |
100,000
+50,000
| +100% | +$454K | 0.01% | 905 |
|
|
2022
Q1 | $508K | Buy |
+50,000
| New | +$508K | 0.01% | 851 |
|
|
2021
Q4 | – | Sell |
-20,000
| Closed | -$937K | – | 1067 |
|
|
2021
Q3 | $937K | Buy |
+20,000
| New | +$937K | 0.01% | 736 |
|
|
2020
Q3 | – | Sell |
-10,000
| Closed | -$326K | – | 528 |
|
|
2020
Q2 | $326K | Buy |
+10,000
| New | +$326K | 0.01% | 410 |
|